Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Tcg Crossover Fund Ii Lp investment portfolio
Tcg Crossover Fund Ii Lp has made numerous investments in companies such as Beacon Therapeutics Holdings, Pheon Therapeutics, and Vicebio within the Healthcare & Life Sciences sector.
vc
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Beacon Therapeutics Holdings Limited Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders. | Healthcare & Life Sciences | London | Confirmed | 2025-08-17 |
| Pheon Therapeutics Ltd Pheon Therapeutics develops next‑generation antibody‑drug conjugates (ADCs) as targeted therapies for hard‑to‑treat cancers. | Healthcare & Life Sciences | Sandwich | Confirmed | 2025-10-19 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (4)
Tcg Crossover Fund Ii Lp's positions across portfolio companies2026
- SERIES B3 PREFERRED 0 → 7,396,774
2025
- SERIES B 4,084,967 → 8,169,934
Articles (2)
- Chi-Ting Huang Revocable Trust takes 0.1% stake in Pheon Therapeutics22 Aug 2026Pheon Therapeutics
- Advent Life Sciences Fund III takes 3.1% of Beacon Therapeutics21 Aug 2026Beacon Therapeutics Holdings